Butamirate

Records for this ingredient, by country (identity only).

ATC — · 2 markets · 31 records

Butamirate 2 markets · 31 records Forms
Filters
MarketCZ 29LV 2
Kind

CZ 29 records · 8 shown of 8 Source Státní ústav pro kontrolu léčiv (S · Data as of 2026-11-01

Only this ingredient

  • 1.5 mg per mL / per unit basis not statedliquidSINECODTUSSICAL
  • 50 mgtablet · extended-releaseSINECOD
  • 46.2 mg per mL / per unit basis not statedliquidTUSSIN
  • 7.5 mg per mL / per unit basis not statedliquidTUSSICAL
  • 5 mg per mL / per unit basis not statedliquidSINECOD

Combination products containing this ingredient

  • 4 mgtablet CombinationButamirate 4 mg + Guaifenesin 100 mgSTOPTUSSIN also in LV
  • 80 mg per mL / per unit basis not statedliquid CombinationButamirate 80 mg + Guaifenesin 2000 mgSTOPTUSSIN
  • 4 mg per mL / per unit basis not statedliquid CombinationButamirate 4 mg + Guaifenesin 100 mgSTOPTUSSIN

LV 2 records · 2 shown of 2 Source Zāļu valsts aģentūra (ZVA) · Data as of 2026-11-11

Only this ingredient

  • 1.5 mg/1 mLliquidParmenol 1,5 mg/ml šķīdums iekšķīgai lietošanaiParmenol 1.5 mg/ml oral solution

Combination products containing this ingredient

  • 4 mgtablet CombinationButamirate 4 mg + Guaifenesin 100 mgSTOPTUSSINStoptussin 4 mg/100 mg tabletes also in CZ

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.